Structure of B8R 20-27 (H-2Kb)
Logo for Infectious disease
Infectious disease

B8R 20-27 (H-2Kb) TSYKFESV

Product number: EP08851_1

€ 105.00 *

Prices excl. VAT plus shipping costs
Available, delivery time: 1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
Caution: For research use only. Not for use in humans.
Amount in mg
1
Add to Cart

Description

This is amino acids 20 to 27 fragment of B8R, a vaccinia virus (VV) gene that encodes a secreted protein related to gamma interferon receptor (IFN-?). B8R binding to IFN-? neutralizes its antiviral activity.

TechData

Sequence: TSYKFESV
Delivery: 1-3 days
C-Terminus: OH
N-Terminus: H
Amount: 1 mg
Counterion: TFA
Protein: Vaccinia virus WR epitope B8R
UniProt Id: P24770, Q66793, G0XTP5
IEDB Id: 66504
Species: Vaccinia virus (VACV)
Allele: H-2Kb
Application: Flow Cytometry
Indication: Infectious disease, Control
Purity: 95% HPLC-MS

References

  1. Flesch, Inge E A et al. “Extent of Systemic Spread Determines CD8+ T Cell Immunodominance for Laboratory Strains, Smallpox Vaccines, and Zoonotic Isolates of Vaccinia Virus.” Journal of immunology, vol. 195,5 (2015): 2263-72. doi:10.4049/jimmunol.1402508
  2. Kaynarcalidan, Onur et al. “Vaccinia Virus: From Crude Smallpox Vaccines to Elaborate Viral Vector Vaccine Design.” Biomedicines vol. 9,12 1780. 26 Nov. 2021, doi:10.3390/biomedicines9121780
  3. Jacobs, Bertram L et al. “Vaccinia virus vaccines: past, present and future.” Antiviral research vol. 84,1 (2009): 1-13. doi:10.1016/j.antiviral.2009.06.006
  4. Andreacchio, Giuseppe et al. “Viral Vector-Based Chlamydia trachomatis Vaccines Encoding CTH522 Induce Distinct Immune Responses in C57BL/6J and HLA Transgenic Mice.” Vaccines vol. 12,8 944. 22 Aug. 2024, doi:10.3390/vaccines12080944